The Juvenile Diabetes Research Foundation, the world's leading charitable funder of type 1 diabetes research, announced today that they have formed a partnership with MacroGenics, Inc., a Maryland-based biotechnology company that specializes in developing therapeutics for autoimmune diseases, cancer and infectious diseases. [click link for full article]
More...